Both in Pharmaceuticals
Xenetic Biosciences vs Processa Pharmaceuticals
Over the past year XBIO returned −33.3% and PCSA returned −79.0%; their daily moves had a correlation of 0.07.
XBIO −33.3% PCSA −79.0%Growth of $1, one year, split-adjusted
| Metric | XBIO | PCSA |
|---|---|---|
| Price | $2.08 | $1.94 |
| Market cap | $4.9M | $5.4M |
| Today | +0.97% | +4.86% |
| 1 month | −5.5% | +30.2% |
| 6 months | −32.7% | −27.1% |
| Year to date | −4.1% | −32.6% |
| 1 year | −37.7% | −80.1% |
| Revenue growth (YoY) | +12.0% | — |
| Gross margin | 100.0% | — |
| Net margin | −140.7% | — |
| P/E (TTM) | — | — |
| Price / sales | 3.3× | — |
| Net cash | $6.5M | $196.3K |
| Dividend yield | — | — |
| Volatility (60d) | 158.7% | 87.6% |
| Short % of float | 0.5% | 2.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).